CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era-Reference-Cited by-同舟云学术

CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era

Published:2018-11-13 Issue:17 Volume:32 Page:2605-2614
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Roul Hélène,Mary-Krause Murielle,Ghosn Jade,Delaugerre Constance,Pialoux Gilles,Cuzin Lise,Launay Odile,Lacombe Jean-Marc,Menard Amélie,De Truchis Pierre,Delfraissy Jean-François,Weiss Laurence,Costagliola Dominique

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference33 articles.

1. CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater;Gras;J Acquir Immune Defic Syndr,2007

2. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study;Kaufmann;Arch Intern Med,2003

3. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression;Moore;Clin Infect Dis,2007

4. CD4 cell count at initiation of ART, long-term likelihood of achieving CD4 >750 cells/mm3 and mortality risk;Palella;J Antimicrob Chemother,2016

5. Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals;Okulicz;JAMA Intern Med,2015

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trajectories of CD4 T‐cell count, CD8 T‐cell count, and CD4/CD8 ratio in patients with HIV and long‐term virological suppression based on Yunnan HIV cohort;HIV Medicine;2024-09-02

2. Microvascular Changes during Viral Infections: A Systematic Review of Studies Using Retinal Vessel Diameter Assessments;Biomedicines;2024-07-05

3. HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study;Emerging Microbes & Infections;2024-06-27

4. The Prognosis for Delayed Immune Recovery in HIV-Infected Children might be Associated with Pre-cART CD4 + T cell Count Irrespective of Co-Infection with Tuberculosis;2024-04-19

5. The temporal relationship between body composition and cardiometabolic profiles in an HIV-infected (on antiretroviral therapy) versus HIV-free Western Cape study population;CARDIOVASC J AFR;2024